A federal jury came back with a defense verdict late Thursday night after two weeks of trial in New Orleans.
November 19, 2021 at 12:18 PM
3 minute read
staff reporter
Sanofi-Aventis has won its second bellwether verdict over its chemotherapy drug Taxotere.
A federal jury came back with a defense verdict late Thursday night after two weeks of trial in New Orleans. The trial is the second bellwether from among nearly 12,500 lawsuits coordinated in multidistrict litigation alleging that women who take Taxotere, which is used to treat breast cancer, never grow back their hair. The first bellwether trial ended in a defense verdict in 2019.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
